Estradiol Tablet

For decades, oral estradiol was the default delivery route in menopause research. That depth of evidence is one reason oral remains an active, well-supported option — we know in detail how it works, who responds, and what to watch for.

Oral estradiol does pass through the liver before entering general circulation. That first-pass metabolism modestly raises clotting-factor production, which is why current guidelines lean transdermal for women with VTE risk factors. For women without those risk factors, oral remains a reasonable choice, particularly when transdermal isn't tolerated, isn't preferred, or hasn't worked.

Many women simply prefer a pill. If it gets taken, it works. Your clinician balances your full picture — symptoms, history, lifestyle, what's been tried — before recommending a route.

Most common: mild breast tenderness, mild nausea (usually settles within a couple of weeks), light spotting in the first cycles. These typically resolve as your body adjusts.

Less common but worth flagging: persistent breast tenderness, headache, mood changes, irregular bleeding past the first 3 months. Tell your clinician — usually a strength or schedule adjustment resolves it.

Not appropriate if: you have a personal history of breast cancer, certain estrogen-sensitive cancers, active liver disease, a history of unprovoked blood clots or stroke, unexplained vaginal bleeding, migraine with aura, or you're pregnant. Oral specifically is generally avoided when VTE risk is elevated — in those cases, transdermal is preferred. Your assessment surfaces these factors carefully.

If you have a uterus: you'll also need progesterone (or a combination preparation) to protect the uterine lining. Your clinician decides which.